Amgen Inc.
AMGN
$305.70
-$1.22-0.40%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.55% | 4.99% | 6.40% | 2.01% | 4.48% |
| Total Other Revenue | 26.48% | -14.46% | -3.19% | -48.92% | -50.09% |
| Total Revenue | 19.84% | 3.77% | 5.94% | -2.13% | -0.10% |
| Cost of Revenue | 78.13% | 13.66% | 20.07% | 10.19% | 1.69% |
| Gross Profit | -0.16% | 0.67% | 1.75% | -6.24% | -0.70% |
| SG&A Expenses | 44.66% | 4.12% | -2.49% | 2.44% | 10.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 8,957.14% | -181.82% | -89.48% | -- | -- |
| Total Operating Expenses | 62.38% | 5.43% | -3.58% | 7.74% | 3.23% |
| Operating Income | -69.68% | 1.28% | 25.28% | -16.99% | -6.45% |
| Income Before Tax | -51.26% | -18.60% | 5.42% | 105.49% | -17.97% |
| Income Tax Expenses | -35.61% | -12.85% | 9.81% | 202.01% | -43.10% |
| Earnings from Continuing Operations | -52.54% | -19.27% | 4.71% | 92.48% | -14.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.54% | -19.27% | 4.71% | 92.48% | -14.90% |
| EBIT | -69.68% | 1.28% | 25.28% | -16.99% | -6.45% |
| EBITDA | -34.23% | 2.64% | 20.57% | -10.93% | -2.90% |
| EPS Basic | -52.54% | -19.27% | 4.71% | 97.53% | -10.61% |
| Normalized Basic EPS | -95.21% | 10.80% | -39.77% | 110.75% | -11.45% |
| EPS Diluted | -52.42% | -19.10% | 4.90% | 97.01% | -10.90% |
| Normalized Diluted EPS | -95.22% | 10.80% | -39.78% | 110.33% | -11.64% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | -2.55% | -4.80% |
| Average Diluted Shares Outstanding | 0.19% | 0.00% | 0.00% | -2.36% | -4.60% |
| Dividend Per Share | 9.79% | 9.79% | 9.79% | 9.79% | 10.23% |
| Payout Ratio | 1.31% | 0.36% | 0.05% | -0.45% | 0.23% |
